What’s New in the 2026 Childhood Immunization Schedule? What Parents Should Know
The CDC has released the 2026 Recommended Child and Adolescent Immunization Schedule, endorsed by the American Academy of Pediatrics. Here’s what changed from 2025, what stayed the same, and what U.S. families should review before their child’s next visit.
CDC Releases 2026 Child and Adolescent Immunization Schedule
The Centers for Disease Control and Prevention (CDC) has published the 2026 Recommended Child and Adolescent Immunization Schedule for children and teens from birth through age 18. The schedule is endorsed by the American Academy of Pediatrics (AAP) and other major medical groups.
For most families, the bottom line is reassuring: the core vaccine schedule remains familiar. However, the 2026 update includes clarifications and technical adjustments that may affect certain age groups, product choices, or catch-up timing. Pediatricians will use this updated schedule starting now.
What the Schedule Covers
The child and adolescent schedule applies to:
- Infants and toddlers (birth–23 months)
- Children (2–10 years)
- Preteens and teens (11–18 years)
It includes routine vaccines such as:
- Hepatitis B
- DTaP and Tdap (tetanus, diphtheria, pertussis)
- Polio (IPV)
- Hib
- Pneumococcal (PCV)
- MMR (measles, mumps, rubella)
- Varicella (chickenpox)
- Hepatitis A
- HPV
- Meningococcal vaccines
- Influenza (annual)
- COVID-19
- RSV prevention for eligible infants
The CDC publishes the schedule each year after recommendations are reviewed and voted on by the Advisory Committee on Immunization Practices (ACIP). Updates are formally summarized in the CDC’s Morbidity and Mortality Weekly Report (MMWR).
What Changed in 2026
According to the CDC’s 2026 schedule and MMWR notice, changes from 2025 include:
1. Updated COVID-19 Vaccine Guidance
The schedule reflects the most current CDC recommendations for the 2025–2026 COVID-19 vaccine formulation. As in recent years:
- COVID-19 vaccination remains recommended for children 6 months and older.
- Dosing depends on age and prior vaccination history.
- Additional doses may be recommended for certain immunocompromised children.
The 2026 schedule reorganizes some footnotes to clarify product-specific guidance and simplify age-based tables for clinicians and families.
2. RSV Prevention Clarifications for Infants
The 2026 schedule continues to include RSV prevention guidance for infants, using either:
- Maternal RSV vaccination during pregnancy, or
- Nirsevimab, a long-acting monoclonal antibody given to most infants during their first RSV season.
The updated schedule clarifies eligibility for certain high-risk toddlers entering a second RSV season and aligns wording with current ACIP recommendations.
3. Pneumococcal Vaccine Notes and Catch-Up Guidance
The 2026 version includes technical updates to pneumococcal vaccine (PCV) footnotes. These changes help clinicians determine appropriate catch-up schedules and product options if doses were delayed or if different PCV products were used.
For most healthy children following the routine series on time, the recommendations are unchanged.
4. Table and Footnote Refinements
Each year, CDC adjusts formatting and footnotes to improve clarity. In 2026, revisions include:
- Clearer catch-up tables for children who start late or fall behind
- Refined language for special risk groups (such as children with certain chronic medical conditions)
- Alignment with any FDA-approved age expansions reflected in ACIP guidance
These are primarily technical improvements rather than new vaccine additions.
What Stayed the Same
It is important not to overstate change. The 2026 schedule continues to recommend:
- Routine infant series beginning at birth (Hepatitis B)
- Primary series at 2, 4, and 6 months
- MMR and varicella at 12–15 months
- Boosters at 4–6 years
- HPV starting at 11–12 years
- Meningococcal ACWY at 11–12 years with booster at 16
- Annual influenza vaccination for everyone 6 months and older
In other words, most children will continue following a familiar timeline.
How ACIP Develops Vaccine Recommendations
The Advisory Committee on Immunization Practices (ACIP) is a federal advisory panel that reviews clinical trials, safety data, real-world effectiveness studies, and cost-effectiveness analyses before making recommendations.
ACIP meetings are public. After discussion and voting, recommendations are published in the CDC’s MMWR. Once adopted by CDC leadership, they become official CDC guidance and are incorporated into the annual immunization schedule.
The American Academy of Pediatrics formally reviews and endorses the schedule for pediatric practice.
What This Means for Pediatric Visits
At your child’s next appointment:
- Bring your child’s immunization record.
- Ask whether any 2026 updates affect timing or product choices.
- If your child fell behind during the pandemic or after moving, review catch-up options.
Most visits will proceed as usual. The schedule update mainly ensures clinicians are using the most current evidence and labeling.
School Requirements: Similar but Not Identical
CDC recommendations do not automatically change state school vaccine requirements. Each state sets its own mandates for school and childcare entry.
However, states often align requirements with CDC schedules. Parents should check their state health department website for current school-entry rules.
How Vaccine Safety Is Monitored
Vaccines in the schedule are continuously monitored for safety through several systems:
- VAERS (Vaccine Adverse Event Reporting System), an early warning system co-managed by CDC and FDA.
- Vaccine Safety Datalink, which analyzes health data from large health systems to detect rare side effects.
- Clinical Immunization Safety Assessment (CISA) Project, which evaluates complex safety questions.
Most vaccine side effects are mild, such as soreness or low fever. Rare serious events are investigated carefully, and recommendations are adjusted if needed.
Cost and Insurance Coverage
Under the Affordable Care Act, vaccines recommended by ACIP are generally covered by private insurance plans without cost-sharing when provided by an in-network provider.
For eligible families, the federally funded Vaccines for Children (VFC) Program, administered by HRSA, provides vaccines at no cost for:
- Children enrolled in Medicaid
- Uninsured children
- American Indian and Alaska Native children
- Underinsured children receiving care at federally qualified health centers or rural health clinics
If cost is a concern, ask your pediatrician whether your child qualifies for VFC.
The Practical Takeaway for Parents
The 2026 childhood immunization schedule keeps the same overall structure families are used to. Updates primarily clarify COVID-19, RSV, pneumococcal, and catch-up guidance rather than adding entirely new routine vaccines.
The most important step is simple: review the updated schedule with your pediatrician and stay on track. Vaccination protects individual children and helps reduce outbreaks in schools and communities.
If you’re unsure whether your child is up to date, your pediatrician can quickly check and create a catch-up plan if needed.
Sources
- https://www.cdc.gov/vaccines/hcp/imz-schedules/child-adolescent.html
- https://www.cdc.gov/mmwr/
- https://www.aap.org/en/patient-care/immunizations/
- https://www.hrsa.gov/vaccines-for-children
This article is for general informational purposes only and is not medical advice. Research findings can be early, limited, or subject to change as new evidence emerges. For personal guidance, diagnosis, or treatment, consult a licensed clinician. For current outbreak or public health guidance, follow your local health department, the CDC, or another relevant public health authority.
